Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes

Diabetes

Volumn 62, Issue 9, 2013, Pages 3005-3013

  Breen, Danna M ^a,b   Rasmussen, Brittany A ^a,b   Côté, Clémence D ^a,b   Jackson, V Margaret ^c   Lam, Tony K T ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PFIZER INC   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COENZYME A; INSULIN; LONG CHAIN FATTY ACID; GLUCOSE;

ANTIDIABETIC ACTIVITY; BARIATRIC SURGERY; DIABETES MELLITUS; DUODENUM; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE FUNCTION; METABOLIC REGULATION; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE ABSORPTION; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; SMALL INTESTINE;

BLOOD GLUCOSE; GASTROINTESTINAL TRACT; GLUCOSE; HUMANS; INTESTINE, SMALL;

EID: 84887365220     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0523     Document Type: Review

References (89)

1. Scully T. Diabetes in numbers. Nature 2012;485:S2-S3
2. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806
3. Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA 2010;107:17391-17396
4. German JP, Thaler JP, Wisse BE, et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hy-perglycemia. Endocrinology 2011;152:394-404
5. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci USA 2010;107:4813-4819
6. Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med 2012;18:950-955
7. Jiao J, Bae EJ, Bandyopadhyay G, et al. Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats. Diabetes 2013;62:1074-1083
8. Unger RH, Cherrington AD. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest 2012;122: 4-12
9. Chari M, Lam CK, Wang PY, Lam TK. Activation of central lactate metabolism lowers glucose production in uncontrolled diabetes and diet-induced insulin resistance. Diabetes 2008;57:836-840
10. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science 2005;307:1909-1914
11. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007;117:13-23
12. Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med 2010;16:392-395
13. Breen DM, Yang CS, Lam TK. Gut-brain signalling: how lipids can trigger the gut. Diabetes Metab Res Rev 2011;27:113-119
14. Wang PY, Caspi L, Lam CK, et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008;452:1012-1016
15. Chang CH, Chey WY, Chang TM. Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretin. Am J Physiol Gas-trointest Liver Physiol 2000;279:G295-G303
16. Takahashi A, Tanaka S, Miwa Y, et al. Involvement of calmodulin and protein kinase C in cholecystokinin release by bombesin from STC-1 cells. Pancreas 2000;21:231-239
17. Kokorovic A, Cheung GW, Breen DM, Chari M, Lam CK, Lam TK. Duodenal mucosal protein kinase C-d regulates glucose production in rats. Gastro-enterology 2011;141:1720-1727
18. Breen DM, Yue JT, Rasmussen BA, Kokorovic A, Cheung GW, Lam TK. Duodenal PKC-d and cholecystokinin signaling axis regulates glucose production. Diabetes 2011;60:3148-3153
19. Cheung GW, Kokorovic A, Lam CK, Chari M, Lam TK. Intestinal chole-cystokinin controls glucose production through a neuronal network. Cell Metab 2009;10:99-109
20. Broberger C, Holmberg K, Shi TJ, Dockray G, Hökfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 2001;903:128-140
21. Rasmussen BA, Breen DM, Luo P, et al. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 2012;142:834-843, e3
22. Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endo-cannabinoid and fatty acid receptors. PLoS ONE 2012;7:e42373
23. McLaughlin J, Grazia Lucà M, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999;116: 46-53
24. Habib AM, Richards P, Rogers GJ, Reimann F, Gribble FM. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. Diabetologia 2013;56:1413-1416
25. Jordan J, Greenway FL, Leiter LA, et al. Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients. Clin Pharmacol Ther 2008;83:281-287
26. Williams JA, Blevins GT Jr. Cholecystokinin and regulation of pancreatic acinar cell function. Physiol Rev 1993;73:701-723
27. Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984;220:345-360
28. Marino CR, Leach SD, Schaefer JF, Miller LJ, Gorelick FS. Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas. FEBS Lett 1993;316:48-52
29. Simonsson E, Karlsson S, Ahrén B. Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets. Regul Pept 1996;65:101-107
30. Lee J, Cummings BP, Martin E, et al. Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2012;302:R657-R666
31. Lardinois CK, Starich GH, Mazzaferri EL. The postprandial response of gastric inhibitory polypeptide to various dietary fats in man. J Am Coll Nutr 1988;7:241-247
32. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165
33. Ding WG, Gromada J. Protein kinase A-dependent stimulation of exo-cytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide. Diabetes 1997;46:615-621
34. Waget A, Cabou C, Masseboeuf M, et al. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 2011;152:3018-3029
35. Chapman IM, Goble EA, Wittert GA, Horowitz M. Effects of small-intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men. Am J Clin Nutr 1999;69:6-12
36. Woltman T, Reidelberger R. Effects of duodenal and distal ileal infusions of glucose and oleic acid on meal patterns in rats. Am J Physiol 1995;269: R7-R14
37. Knauf C, Cani PD, Kim DH, et al. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes 2008;57:2603-2612
38. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008;8:201-211
39. Spiller RC, Trotman IF, Higgins BE, et al. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984;25:365-374
40. Lin HC, Doty JE, Reedy TJ, Meyer JH. Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient. Am J Physiol 1990;259:G1031-G1036
41. Lin HC, Zhao XT, Wang L. Fat absorption is not complete by midgut but is dependent on load of fat. Am J Physiol 1996;271:G62-G67
42. Meyer JH, Elashoff JD, Doty JE, Gu YG. Disproportionate ileal digestion on canine food consumption. A possible model for satiety in pancreatic insufficiency. Dig Dis Sci 1994;39:1014-1024
43. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R, Tso P. Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am J Physiol 1997;272:R1170-R1177
44. Holgate AM, Read NW. Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose. Dig Dis Sci 1983;28:812-819
45. Jian R, Pecking A, Najean Y, Bernier JJ. [Study of the progression of an ordinary meal in the human small bowel by a scintigraphic method (author's transl)]. Gastroenterol Clin Biol 1979;3:755-762 [in French]
46. Ogawa N, Ito M, Yamaguchi H, et al. Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats. Metabolism 2012;61:1312-1320
47. Dailey MJ, Tamashiro KL, Terrillion CE, Moran TH. Nutrient specific feeding and endocrine effects of jejunal infusions. Obesity (Silver Spring) 2010;18:904-910
48. Dailey MJ, Moghadam AA, Moran TH. Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass. Am J Physiol Endocrinol Metab 2011;301:E1184-E1190
49. Drewe J, Gadient A, Rovati LC, Beglinger C. Role of circulating chole-cystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology 1992;102:1654-1659
50. Ogawa N, Yamaguchi H, Shimbara T, et al. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats. Neurosci Lett 2008;433:38-42
51. Randich A, Chandler PC, Mebane HC, et al. Jejunal administration of linoleic acid increases activity of neurons in the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 2004;286: R166-R173
52. Lal S, Kirkup AJ, Brunsden AM, Thompson DG, Grundy D. Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol 2001;281:G907-G915
53. Rasmussen BA, Breen DM, Lam TK. Lipid sensing in the gut, brain and liver. Trends Endocrinol Metab 2012;23:49-55
54. Buffa R, Solcia E, Go VL. Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa. Gastroenterology 1976;70: 528-532
55. Larsson LI, Rehfeld JF. Distribution of gastrin and CCK cells in the rat gastrointestinal tract. Evidence for the occurrence of three distinct cell types storing COOH-terminal gastrin immunoreactivity. Histochemistry 1978;58:23-31
56. Polak JM, Bloom SR, Rayford PL, Pearse AG, Buchan AM, Thompson JC. Identification of cholecystokinin-secreting cells. Lancet 1975;2:1016-1018
57. Sayegh AI, Ritter RC. CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine. Regul Pept 2000;88:75-81
58. Suzuki K, Jayasena CN, Bloom SR. Obesity and appetite control. Exp Diabetes Res 2012;2012:824305
59. Ferraris RP, Diamond J. Regulation of intestinal sugar transport. Physiol Rev 1997;77:257-302
60. Caspi L, Wang PY, Lam TK. A balance of lipid-sensing mechanisms in the brain and liver. Cell Metab 2007;6:99-104
61. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012;379:2300-2311
62. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366: 1567-1576
63. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366: 1577-1585
64. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-323
65. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012;35:1420-1428
66. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004;239:1-11
67. Lee HC, Kim MK, Kwon HS, Kim E, Song KH. Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg 2010;20:1530-1535
68. Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007;3:195-197
69. Gavin TP, Sloan RC 3rd, Lukosius EZ, et al. Duodenal-jejunal bypass surgery does not increase skeletal muscle insulin signal transduction or glucose disposal in Goto-Kakizaki type 2 diabetic rats. Obes Surg 2011;21:231-237
70. Kindel TL, Martins PJ, Yoder SM, et al. Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. Obesity (Silver Spring) 2011;19:380-387
71. Wilson-Pérez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide-1 receptor deficiency. Diabetes 2013;62:2380-2385
72. Czupryniak L, Wiszniewski M, Szymanski D, Pawtowski M, Loba J, Strzelczyk J. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg 2010;20:506-508
73. Ley RE, Hamady M, Lozupone C, et al. Evolution of mammals and their gut microbes. Science 2008;320:1647-1651
74. Lepage P, Colombet J, Marteau P, Sime-Ngando T, Doré J, Leclerc M. Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 2008;57:424-425
75. Turnbaugh, PJ, Ridaura, VK, Faith, JJ, Rey, FE, Knight, R, Gordon, JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14, 2009
76. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009;137:1716-1724
77. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031
78. Serino M, Luche E, Gres S, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012;61:543-553
79. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-916, e7
80. Ding S, Chi MM, Scull BP, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010;5:e12191
81. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-1481
82. Swann JR, Want EJ, Geier FM, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011;108(Suppl. 1):4523-4530
83. Claus SP, Tsang TM, Wang Y, et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol 2008;4: 219
84. Swartz TD, Duca FA, de Wouters T, Sakar Y, Covasa M. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 2012;107:621-630
85. Duca FA, Swartz TD, Sakar Y, Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 2012;7:e39748
86. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108:16050-16055
87. Burcelin R. Regulation of metabolism: a cross talk between gut microbiota and its human host. Physiology (Bethesda) 2012;27:300-307
88. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009;106:2365-2370
89. Uribe A, Alam M, Johansson O, Midtvedt T, Theodorsson E. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gas-troenterology 1994;107:1259-1269